A putative right anterior insula metabolism biomarker predictive of treatment outcomes was retrospectively applied to 30 depressed psychotherapy--or escitalopram-treated nonremitters who entered combination treatment. Patients whose added treatment matched the biomarker-indicated treatment remitted more often than biomarker-mismatched patients.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788472 | PMC |
http://dx.doi.org/10.1176/appi.neuropsych.14030048 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!